91
Views
29
CrossRef citations to date
0
Altmetric
Original Research

Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide

, , , , &
Pages 1051-1062 | Published online: 12 Mar 2013

References

  • StrebhardtKUllrichAPaul Ehrlich’s magic bullet concept: 100 years of progressNat Rev Cancer20088647348018469827
  • HaleyBFrenkelENanoparticles for drug delivery in cancer treatmentUrol Oncol2008261576418190833
  • CabralHMatsumotoYMizunoKAccumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on sizeNat Nanotechnol201161281582322020122
  • PanLHeQLiuJNuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticlesJ Am Chem Soc2012134135722572522420312
  • BarbéCBartlettJKongLSilica particles: a novel drug-delivery systemAdv Mater2004162119591966
  • ChangGLiCLuWDingJN-Boc-histidine-capped PLGA-PEG-PLGA as a smart polymer for drug delivery sensitive to tumor extracellular pHMacromol Biosci201010101248125620593367
  • ChauYTanFELangerRSynthesis and characterization of dextran-peptide-methotrexate conjugates for tumor targeting via mediation by matrix metalloproteinase II and matrix metalloproteinase IXBioconjug Chem200415493194115264885
  • ChoHBaeJGarripelliVKAndersonJMJunHWJoSRedox-sensitive polymeric nanoparticles for drug deliveryChem Commun (Camb)20124860436045
  • DharapSSWangYChandnaPTumor-specific targeting of an anticancer drug delivery system by LHRH peptideProc Natl Acad Sci U S A200510236129621296716123131
  • HatakeyamaSSugiharaKShibataTKTargeted drug delivery to tumor vasculature by a carbohydrate mimetic peptideProc Natl Acad Sci U S A201110849195871959222114188
  • CaiLLLiuPLiXRGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cellsInt J Nanomedicine201163499350822282676
  • LupoldSERodriguezRDisulfide-constrained peptides that bind to the extracellular portion of the prostate-specific membrane antigenMol Cancer Ther20043559760315141017
  • RasmussenUBSchreiberVSchultzHMischlerFSchughartKTumor cell-targeting by phage-displayed peptidesCancer Gene Ther20029760661212082461
  • PasqualiniRRuoslahtiEOrgan targeting in vivo using phage display peptide librariesNature199638065723643468598934
  • ChenYShenYGuoXTransdermal protein delivery by a coadministered peptide identified via phage displayNat Biotechnol200624445546016565728
  • KrumpeLRMoriTThe use of phage-displayed peptide libraries to develop tumor-targeting drugsInt J Pept Res Ther2006121799119444323
  • RuoslahtiEBhatiaSNSailorMJTargeting of drugs and nanoparticles to tumorsEur J Cell Biol20101886759768
  • KorenEApteASawantRRGrunwaldJTorchilinVPCell-penetrating TAT peptide in drug delivery systems: proteolytic stability requirementsDrug Deliv2011185378384
  • SchiavoGPapiniEGennaGMontecuccoCAn intact interchain disulfide bond is required for the neurotoxicity of tetanus toxinInfect Immun19905812413641412254033
  • ChenXBaiYZaroJLShenWCDesign of an in vivo cleavable disulfide linker in recombinant fusion proteinsBiotechniques201049151351820615204
  • ArmishawCJDalyNLNevinSTAdamsDJCraikDJAlewoodPFAlpha-selenoconotoxins, a new class of potent alpha7 neuronal nicotinic receptor antagonistsJ Biol Chem200628120141361414316500898
  • HondalRJNilssonBLRainesRTSelenocyteine in native chemical ligation and expressed protein ligationJ Am Chem Soc2001123215140514111457362
  • MuttenthalerMNevinSTGrishinAASolving the á-conotoxin folding problem: efficient selenium-directed on-resin generation of more potent and stable nicotinic acetylcholine receptor antagonistsJ Am Chem Soc2010132103514352220163143
  • PegoraroSFioriSRudolph-BöhnerSWatanabeTXMoroderLIsomorphous replacement of cystine with selenocystine in endothe-lin: oxidative refolding, biological and conformational properties of [Sec3,Sec11,Nle7]-endothelin-1J Mol Biol199828437797929826515
  • ZengHSelenium as an essential micronutrient: roles in cell cycle and apoptosisMolecules20091431263127819325522
  • LaakkonenPPorkkaKHoffmanJARuoslahtiEA tumor-homing peptide with a targeting specificity related to lymphatic vesselsNat Med20028775175512053175
  • FogalVZhangLLKrajewskiSRuoslahtiEMitochondrial/cell surface protein p32/gC1qR as molecular target in tumor cells and tumor stromaCancer Res200868177210721818757437
  • YanZZhanCWenZLyP-1-conjugated doxorubicin-loaded liposomes suppress lymphatic metastasis by inhibiting lymph node metastases and destroying tumor lymphaticsNanotechnology2011224141510321914940
  • YanZWangFWenZLyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumorJ Control Release2012157111812521827801
  • LuoGYuXJinCLyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumorsInt Pharm20103851–2150156
  • UchidaMKosugeHTerashimaMProtein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesionsACS Nano2011542493250221391720
  • WangZHYuYMaJLyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphaticsMol Pharm2012992646265722853186
  • GuoXShiJTangZCuiDZhangYSynthesis and biological activity of seleno sunflower trypsin inhibitor analogChem Biol Drug Des200668634134417177897
  • CaiWBChenXYPreparation of peptide-conjugated quantum dots for tumor vasculature-targeted imagingNat Protoc200831899618193025
  • NallamothuRWoodGCPattilloCBA tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evalutionAAPS Pharm Sci Tech200672E32
  • DurekTAlewoodPFPreformed selenoesters enable rapid native chemical ligation at intractable sitesAngew Chem Int Ed Engl20115050120421204521997950
  • SunYLiTChenHSelenium-containing 15-mer peptides with high glutathione peroxidase-like activityJ Biol Chem200427936372353724015148324
  • HanTSZhangMMGowdKHDisulfide-depleted selenocono-peptides: simplified oxidative folding of cysteine-rich peptidesACS Med Chem Lett20101414014420676359
  • PeqoraroSFioriSCramerJRudolph-BöhnerSMoroderLThe disulfide-coupled folding pathway of apamin as derived from diselenide-quenched analogs and intermediatesProtein Sci1999881605161310452604
  • FioriSPeqeoraroSRudolph-BöhnerSCramerJMoroderLSynthesis and conformational analysis of apamin analogues with natural and non-natural cystine/selenocystine connectivtiesBiopolymers200053755056410766951
  • RaffaRBDiselenium, instead of disulfide, bonded analogs of conotoxins: novel synthesis and pharmacotherapeutic potentialLife Sci20108715–1645145620691706
  • Understanding the mechanical biology of life’s bonds [webpage on the Internet]New YorkColumbia University2011 Available from: http://news.columbia.edu/fernandezAccessed December 21, 2011
  • LeeSMLeeEJHongHYTargeting bladder tumor cells in vivo and in the urine with a peptide identified by phage displayMol Cancer Res200751111917259343
  • WittHHajdinKIljinKIdentification of a rhabdomyosarcoma targeting peptide by phage display with sequence similarities to the tumor lymphatic-homing peptide LyP-1Int J Cancer200912492026203219123480
  • DongJLiuWJiangAZhangKJChenMQA novel peptide, selected from phage display library of random peptides, can efficiently target into human breast cancer cellChin Sci Bull2008536860867
  • BickelUKangYSPardridgeWMIn vivo cleavability of a disulfide-based chimeric opioid peptide in rat brainBioconjug Chem1995622112187599264
  • PirolloKFChangEHDoes a targeting ligand influence nanoparticle tumor localization or uptake? Trends Biotechnol2008261055255818722682